A citation-based method for searching scientific literature

Meryl Brod, Torsten Christensen, Trine L Thomsen, Donald M Bushnell. Value Health 2011
Times Cited: 186







List of co-cited articles
549 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. Diabetes Care 2013
822
25


Self-reported non-severe hypoglycaemic events in Europe.
C G Östenson, P Geelhoed-Duijvestijn, J Lahtela, R Weitgasser, M Markert Jensen, U Pedersen-Bjergaard. Diabet Med 2014
111
18


Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.
Marc Evans, Kamlesh Khunti, Muhammad Mamdani, Claus B Galbo-Jørgensen, Jens Gundgaard, Mette Bøgelund, Stewart Harris. Health Qual Life Outcomes 2013
115
17

Costs of managing severe hypoglycaemia in three European countries.
Mette Hammer, Morten Lammert, Susana Monereo Mejías, Werner Kern, Brian M Frier. J Med Econ 2009
100
16



Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
Petronella H Geelhoed-Duijvestijn, Ulrik Pedersen-Bjergaard, Raimund Weitgasser, Jorma Lahtela, Marie Markert Jensen, Claes-Göran Östenson. J Med Econ 2013
42
35

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
243
15

Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes.
Ruth E Davis, Malcolm Morrissey, John R Peters, Kim Wittrup-Jensen, Tessa Kennedy-Martin, Craig J Currie. Curr Med Res Opin 2005
169
14

Severe hypoglycemia and risks of vascular events and death.
Sophia Zoungas, Anushka Patel, John Chalmers, Bastiaan E de Galan, Qiang Li, Laurent Billot, Mark Woodward, Toshiharu Ninomiya, Bruce Neal, Stephen MacMahon,[...]. N Engl J Med 2010
962
14

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
L A Donnelly, A D Morris, B M Frier, J D Ellis, P T Donnan, R Durrant, M M Band, G Reekie, G P Leese. Diabet Med 2005
323
13



Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
K Khunti, S Alsifri, R Aronson, M Cigrovski Berković, C Enters-Weijnen, T Forsén, G Galstyan, P Geelhoed-Duijvestijn, M Goldfracht, H Gydesen,[...]. Diabetes Obes Metab 2016
131
13

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.
S R Heller, B M Frier, M L Hersløv, J Gundgaard, S C L Gough. Diabet Med 2016
52
23



Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
11

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Andrew J Palmer, Stéphane Roze, William J Valentine, Michael E Minshall, Volker Foos, Francesco M Lurati, Morten Lammert, Giatgen A Spinas. Curr Med Res Opin 2004
356
11


A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.
Diane Wild, Robyn von Maltzahn, Elaine Brohan, Torsten Christensen, Per Clauson, Linda Gonder-Frederick. Patient Educ Couns 2007
339
10

Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being.
Meryl Brod, Betsy Pohlman, Michael Wolden, Torsten Christensen. Qual Life Res 2013
45
22

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.
Craig J Currie, Christopher Ll Morgan, Chris D Poole, Peter Sharplin, Morten Lammert, Phil McEwan. Curr Med Res Opin 2006
196
10

Increased mortality of patients with diabetes reporting severe hypoglycemia.
Rozalina G McCoy, Holly K Van Houten, Jeanette Y Ziegenfuss, Nilay D Shah, Robert A Wermers, Steven A Smith. Diabetes Care 2012
321
10

Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs.
Carrie Fidler, Torsten Elmelund Christensen, Samantha Gillard. J Med Econ 2011
135
10

Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.
Chloe L Edridge, Alison J Dunkley, Danielle H Bodicoat, Tanith C Rose, Laura J Gray, Melanie J Davies, Kamlesh Khunti. PLoS One 2015
102
10

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
Chantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, John Cooper, Edward Franek, David Russell-Jones, Jens Larsen, Søren Can Tamer, Stephen C Bain. J Clin Endocrinol Metab 2013
149
9


Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
Bernard Zinman, Athena Philis-Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu. Diabetes Care 2012
227
9





Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
425
9

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
489
9

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Alan J Garber, Allen B King, Stefano Del Prato, Seamus Sreenan, Mustafa K Balci, Manuel Muñoz-Torres, Julio Rosenstock, Lars A Endahl, Ann Marie Ocampo Francisco, Priscilla Hollander. Lancet 2012
239
8

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Simon Heller, John Buse, Miles Fisher, Satish Garg, Michel Marre, Ludwig Merker, Eric Renard, David Russell-Jones, Areti Philotheou, Ann Marie Ocampo Francisco,[...]. Lancet 2012
242
8

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes.
T Heise, L Nosek, S G Bøttcher, H Hastrup, H Haahr. Diabetes Obes Metab 2012
226
8


Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.
Elaine Chow, Alan Bernjak, Scott Williams, Robert A Fawdry, Steve Hibbert, Jenny Freeman, Paul J Sheridan, Simon R Heller. Diabetes 2014
232
8

Validation of the IMS CORE Diabetes Model.
Phil McEwan, Volker Foos, James L Palmer, Mark Lamotte, Adam Lloyd, David Grant. Value Health 2014
120
8

Validation of the CORE Diabetes Model against epidemiological and clinical studies.
Andrew J Palmer, Stéphane Roze, William J Valentine, Michael E Minshall, Volker Foos, Francesco M Lurati, Morten Lammert, Giatgen A Spinas. Curr Med Res Opin 2004
214
8

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
8

Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence.
Janice Ms Lopez, Kathy Annunziata, Robert A Bailey, Marcia Ft Rupnow, Donald E Morisky. Patient Prefer Adherence 2014
61
13

Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
Volker Foos, Nebibe Varol, Bradley H Curtis, Kristina S Boye, David Grant, James L Palmer, Phil McEwan. J Med Econ 2015
73
10

Cost of hypoglycemia in patients with Type 2 diabetes in Sweden.
Linus Jönsson, Björn Bolinder, Jonas Lundkvist. Value Health 2006
89
8


10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.